PIK3CG and neoplasm: There is evidence to suggest that different cancer types express different levels of p110 and p85 isoforms (Cortes et al., 2012; Tzenaki et al., 2012), which may lead to tumor type-specific combinations of catalytic and regulatory PI3K subunits.